Autor(es): Moreira, Juliane Almeida ; Laurentino, Marília Rocha ; Machado, Rosângela Pinheiro Gonçalves ; Barbosa, Maritza Cavalcante ; Gonçalves, Ronaldo Pinheiro ; Mota, Amanda de Menezes ; Rocha, Lilianne Brito da Silva ; Martins, Alice Maria Costa ; Arruda, Alcínia Braga de Lima ; Souza, Iêda Pereira de ; Gonçalves, Romélia Pinheiro
Data: 2016
Origem: Oasisbr
Assunto(s): Anemia; Hemoglobina
Objective: This study aimed to evaluate the influence of fetal hemoglobin (Hb F) on hemolysis biomarkers in sickle cell anemia patients. Methods: Fifty adult sickle cell anemia patients were included in the study. All patients were taking hydroxyurea for at least six months and were followed at the outpatient clinic of a hospital in Fortaleza, Ceará, Brazil. The control group consisted of 20 hemoglobin AA individuals. The reticulocyte count was performed by an automated methodology, lac- tate dehydrogenase and uric acid were measured by spectrophotometry and arginase I by enzyme-linked immunosorbent assay (ELISA). The presence of Hb S was detected by high-performance liquid chromatography. The level of significance was set for a p -value <0.05. Results: A significant increase was observed in the reticulocyte count and lactate dehy- drogenase, uric acid and arginase I levels in sickle cell anemia patients compared to the control group ( p -value <0.05). Patients having Hb F levels greater than 10% showed a signifi- cant decrease in the reticulocyte count, arginase I and lactate dehydrogenase. A significant decrease was observed in arginase I levels in patients taking hydroxyurea at a dose greater than 20 mg/kg/day. Conclusion: The results of this study show that sickle cell anemia patients have increases in the hemolysis biomarkers, lactate dehydrogenase, reticulocyte count, arginase I, uric acid and increases in Hb F can reduce the reticulocyte count and arginase I and lactate dehydrogenase levels.
